Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCR4 (clone 1G1G F). We employs the pUC (CMV-YFP-GR-EcoRI) vector components and the SynExpress system of the miRNA Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
human
Target
CCR4
Clone
1G1G F
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
YFP
Promoter
CMV
Effector Gene
GR
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
miRNA
Carrier Type
pUC
Transformation Accuracy
0.99
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.